L-330-2024

Agreement ID
L-330-2024
Lead IC
NIAID
Exclusivity
Nonexclusive
External Party
Meso Scale Diagnostics, LLC (MSD)
Fiscal Year
2025
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-3342     Fusion Glycoprotein Vaccine for Human Metapneumovirus
TAB-3310     Prefusion HPIV F Immunogens and Their Use.
TAB-3429     Prefusion-Stabilized Fusion (F) Glycoprotein Vaccine Immunogens For Human Metapneumovirus